Inventor · disambiguated record
Xiang Li
Also filed as: LI XIANG · LI XIANG DAVID
10 granted patents·9 pending applications·10 citations·filing 2005–2025
80Inventor score
Files withUNIV MARYLAND7UNIV HONG KONG3BLUEVALLEY PHARMACEUTICAL LLC2ROCHE MOLECULAR SYSTEMS INC2BOEHRINGER INGELHEIM PHARMA1
Top patents by PatentIndex Score
19 records- 0185US7368258B1Devices and methods for profiling enzyme substratesUNIV MARYLAND·Filed 2006·Granted May 6, 2008·5 cites·30 claims
- 0279US10525047B2PIM kinase inhibitors in combination with RNA splicing modulators/inhibitors for treatment of cancersUNIV MARYLAND·Filed 2017·Granted Jan 7, 2020·2 cites·6 claims
- 0370US2025101482A1Heteroduplex theromstable ligation assembly (htla) and/or cyclic heteroduplex thermostable ligation assembly (chtla) for generating double-stranded dna fragments with single-stranded sticky endsUNIV MARYLAND·Filed 2024·Application pending·0 cites
- 0467US10143625B2Pharmaceutical reconstitutionRECON THERAPEUTICS INC·Filed 2015·Granted Dec 4, 2018·3 cites·12 claims
- 0565US2025163395A1Systems and methods of novel crispr-cas proteins for in-vitro applicationsROCHE MOLECULAR SYSTEMS INC·Filed 2024·Application pending·0 cites
- 0664US7666617B2Devices and methods for profiling enzyme substratesUNIV MARYLAND·Filed 2008·Granted Feb 23, 2010·0 cites·26 claims
- 0763US2023355705A1Discovery of yeats2 yeats domain inhibitors as novel anti-cancer agentsUNIV HONG KONG·Filed 2023·Application pending·0 cites
- 0862US10842785B2PIM kinase inhibitors in combination with RNA splicing modulators/inhibitors for treatment of cancersUNIV MARYLAND·Filed 2019·Granted Nov 24, 2020·0 cites·6 claims
- 0958US2022227755A1Substituted pyrrolopyridines as atr inhibitorsBLUEVALLEY PHARMACEUTICAL LLC·Filed 2022·Application pending·0 cites
- 1058US2023272370A1Genetically encoded yeats domain probe and applications thereofUNIV HONG KONG·Filed 2021·Application pending·0 cites
- 1157US2025223659A1Methods and uses of crispr cascade reactions for crispr diagnosticsROCHE MOLECULAR SYSTEMS INC·Filed 2025·Application pending·0 cites
- 1253US11236089B2Substituted pyrrolopyridines as ATR inhibitorsBLUEVALLEY PHARMACEUTICAL LLC·Filed 2020·Granted Feb 1, 2022·0 cites·5 claims
- 1352US11389440B2PIM kinase inhibitors in combination with autophagy inhibitors for treatment of cancersUNIV MARYLAND·Filed 2018·Granted Jul 19, 2022·0 cites·7 claims
- 1451US2022089638A1Dithiocarbamate stapled peptides and methods of making and use thereofUNIV MARYLAND·Filed 2020·Application pending·0 cites
- 1550US2022090090A1A method for assembling circular and linear dna molecules in an ordered mannerUNIV OF MARLYLAND BALTIMORE COUNTY·Filed 2020·Application pending·0 cites
- 1648US2015290078A1Reconstitution of pharmaceuticals for injectionMASSACHUSETTS INST TECHNOLOGY·Filed 2014·Application pending·0 cites
- 1745US11512111B2Yeats inhibitors and methods of use thereofUNIV HONG KONG·Filed 2018·Granted Nov 29, 2022·0 cites·21 claims
- 1842US7951933B2CD38 splice variants and uses thereofBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted May 31, 2011·0 cites·5 claims
- 1934US10208065B2Crystalline free bases of C-Met inhibitor or crystalline acid salts thereof, and preparation methods and uses thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2015·Granted Feb 19, 2019·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Xiang Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →